Area of research
Parasitology · Cancer Research
Research interest
Research focused on Cryptosporidium and Cryptosporidium parvum, with related work in Cancer research, Faecalibacterium prausnitzii, PCAF. Notable publications include 'A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium', 'Faecalibacterium prausnitzii ‐derived microbial anti‐inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression', and 'm6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation'.
Targeting Apicomplexan Parasites: Structural and Functional Characterization of <i>Cryptosporidium</i> Thioredoxin Reductase as a Novel Drug Target
Cryptosporidial Infection Suppresses Intestinal Epithelial Cell MAPK Signaling Impairing Host Anti-Parasitic Defense
m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation
<i>Faecalibacterium prausnitzii</i>‐derived microbial anti‐inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression
Induction of a Long Noncoding RNA Transcript, NR_045064, Promotes Defense Gene Transcription and Facilitates Intestinal Epithelial Cell Responses against <i>Cryptosporidium</i> Infection
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells